NCT03160768View on ClinicalTrials.gov

Feasibility of Isolating P16 Expression

CompletedOBSERVATIONAL
Enrollment

85

Participants

Timeline

Start Date

May 25, 2017

Primary Completion Date

May 2, 2019

Study Completion Date

May 2, 2019

Conditions
Childhood Cancer
Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

Sponsors

Collaborators (1)

Sapere Bio
All Listed Sponsors
collaborator

Sapere Bio

INDUSTRY

lead

St. Jude Children's Research Hospital

OTHER

NCT03160768 - Feasibility of Isolating P16 Expression | Biotech Hunter | Biotech Hunter